Vestal Point Capital’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$35.6M	Buy	1,750,000 +1,551,354	+781%	+$31.6M	1.88%	18
2025 Q1	$3.61M	Sell	198,646 -106,354	-35%	-$1.93M	0.26%	49
2024 Q4	$7.71M	Buy	+305,000	New	+$7.71M	0.46%	48